Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C192 - Multiple Sclerosis Disease-modifying Treatment

Thursday 04/18/24
07:00 AM - 09:00 AM MDT Add To Calendar
Colorado Convention Center | Mile High 2/3
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Veronica Kate Penyak Cipriani, MD
Multiple Sclerosis
Participants should be able to identify all current options for disease-modifying treatments for multiple sclerosis; comprehend the mechanism of action of each medication, as well as the potential side effects; and judge which DMTs would be appropriate for individual patients with multiple sclerosis.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Introductory
Brain Health
Fellow, Resident, General Neurologist, Advanced Practice Provider
Case-based, Didactic

Program Materials

Event Timeline
07:00 AM - 07:30 AM MDT Speaker Multiple Sclerosis Overview
Veronica Kate Penyak Cipriani, MD
07:30 AM - 08:00 AM MDT Speaker Mechanism of Action and Efficacy of Disease Modifying Treatments
Marwa Kaisey, MD
08:00 AM - 08:30 AM MDT Speaker Side Effects and Monitoring Recommendations for Disease Modifying Treatments
Daniel Peter Kurz, MD
08:30 AM - 09:00 AM MDT Speaker Case Discussion
Veronica Kate Penyak Cipriani, MD, Marwa Kaisey, MD, Daniel Peter Kurz, MD
Faculty Disclosures
Veronica Kate Penyak Cipriani, MD Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Penyak Cipriani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Pharmaceuticals. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Penyak Cipriani has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Penyak Cipriani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Penyak Cipriani has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Penyak Cipriani has received research support from Genentech.
Marwa Kaisey, MD Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Kaisey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Eichhorn & Eichhorn, LLP. Dr. Kaisey has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Venable LLC. The institution of Dr. Kaisey has received research support from NMSS. The institution of Dr. Kaisey has received research support from Race to Erase MS.
Daniel Peter Kurz, MD Dr. Kurz has nothing to disclose.